MCID: FBR003
MIFTS: 41

Fibrous Histiocytoma

Categories: Cancer diseases, Skin diseases

Aliases & Classifications for Fibrous Histiocytoma

MalaCards integrated aliases for Fibrous Histiocytoma:

Name: Fibrous Histiocytoma 12 15
Histiocytoma, Benign Fibrous 43 71
Benign Fibrous Histiocytoma 12
Histiocytoma Fibrous 54
Fibroxanthoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4415
MeSH 43 D018219
NCIt 49 C3739
SNOMED-CT 67 25889007
UMLS 71 C0206644

Summaries for Fibrous Histiocytoma

MalaCards based summary : Fibrous Histiocytoma, also known as histiocytoma, benign fibrous, is related to histiocytoma, angiomatoid fibrous and myxofibrosarcoma. An important gene associated with Fibrous Histiocytoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are Transcriptional misregulation in cancer and Striated Muscle Contraction. The drugs Etoposide and Epirubicin have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and breast, and related phenotype is respiratory system.

Wikipedia : 74 A dermatofibroma, or benign fibrous histiocytomas, is a benign skin... more...

Related Diseases for Fibrous Histiocytoma

Diseases related to Fibrous Histiocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 721)
# Related Disease Score Top Affiliating Genes
1 histiocytoma, angiomatoid fibrous 34.6 DES CREB1
2 myxofibrosarcoma 33.1 S100B FUS DES
3 tenosynovial giant cell tumor 32.1 SERPINA3 CD68 CD34 CD163
4 malignant fibroxanthoma 31.7 VIM SERPINA3 MFHAS1 F13A1 DES CD68
5 rare tumor 31.7 EWSR1 DES ACTC1
6 cutaneous fibrous histiocytoma 31.5 VIM SERPINA3 S100B MITF F13A1 DES
7 myxoid liposarcoma 31.2 FUS EWSR1 ATF1
8 inflammatory mfh 31.1 SERPINA3 CD68
9 lymphoplasmacyte-rich meningioma 31.0 CD68 CD163
10 fibrosarcoma 30.9 VIM EWSR1 DES ALK ACTC1
11 well-differentiated liposarcoma 30.7 FUS EWSR1 CD34
12 embryonal sarcoma 30.7 VIM SERPINA3 S100B DES
13 fibromatosis 30.7 VIM DES ACTC1
14 sarcomatosis 30.7 EWSR1 ATF1
15 retroperitoneal sarcoma 30.6 EWSR1 CD34
16 malignant mesenchymoma 30.6 SERPINA3 DES CD34
17 rhabdoid tumor predisposition syndrome 1 30.6 VIM DES ACTC1
18 extraskeletal chondroma 30.6 SERPINA3 EWSR1
19 juvenile xanthogranuloma 30.6 SERPINA3 S100B F13A1
20 carcinosarcoma 30.5 VIM DES ACTC1
21 histiocytic sarcoma 30.5 CD68 CD163
22 myoepithelioma 30.5 VIM S100B EWSR1 ACTC1
23 reticulum cell sarcoma 30.5 VIM DES ACTC1
24 xanthogranulomatous pyelonephritis 30.4 SERPINA3 CD68
25 cystadenocarcinoma 30.4 VIM SERPINA3 ACTC1
26 chordoma 30.4 VIM SERPINA3 S100B MTAP DES
27 dedifferentiated liposarcoma 30.4 DES ACTC1
28 pleomorphic lipoma 30.4 SERPINA3 CD34
29 eccrine porocarcinoma 30.3 VIM S100B
30 meningothelial meningioma 30.3 SERPINA3 ENO2
31 vulvar sarcoma 30.3 CD34 ACTC1
32 malignant giant cell tumor 30.3 S100B CD68 ACTC1
33 pyogenic granuloma 30.2 CD34 ACTC1
34 ectomesenchymoma 30.2 ENO2 DES
35 parachordoma 30.2 VIM DES ACTC1
36 fasciitis 30.2 VIM DES CD34 ACTC1
37 sclerosing liposarcoma 30.2 FUS CD34
38 mucinous cystadenocarcinoma 30.2 VIM SERPINA3 ACTC1
39 myxoid chondrosarcoma 30.2 S100B MTAP EWSR1 CD68
40 leiomyoma 30.1 VIM DES CD34 ACTC1
41 liposarcoma 30.1 VIM FUS EWSR1 DES CD68 CD34
42 spindle cell sarcoma 30.1 VIM SERPINA3 S100B DES CD34 ACTC1
43 cutaneous leiomyosarcoma 30.1 VIM S100B DES ACTC1
44 giant cell tumor 30.1 VIM SERPINA3 S100B DES CD68 ACTC1
45 extraosseous osteosarcoma 30.1 CD68 CD34
46 sarcomatoid squamous cell skin carcinoma 30.1 SERPINA3 CD34
47 syringocystadenoma papilliferum 30.1 SERPINA3 S100B DES ACTC1
48 benign ependymoma 30.0 VIM S100B ENO2
49 heart sarcoma 30.0 PECAM1 CD34
50 desmoid tumor 30.0 DES CD34 ACTC1

Graphical network of the top 20 diseases related to Fibrous Histiocytoma:



Diseases related to Fibrous Histiocytoma

Symptoms & Phenotypes for Fibrous Histiocytoma

MGI Mouse Phenotypes related to Fibrous Histiocytoma:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 respiratory system MP:0005388 9.23 ALK CD163 CREB1 ENO2 F13A1 MTAP

Drugs & Therapeutics for Fibrous Histiocytoma

Drugs for Fibrous Histiocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 104)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 3 33419-42-0 36462
2
Epirubicin Approved Phase 3 56420-45-2 41867
3
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
4
Dactinomycin Approved, Investigational Phase 3 50-76-0 2019 457193
5
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
6
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
7
Daunorubicin Approved Phase 2, Phase 3 20830-81-3 30323
8
Lenograstim Approved, Investigational Phase 3 135968-09-1
9
Doxorubicin Approved, Investigational Phase 2, Phase 3 23214-92-8 31703
10
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
11 Antirheumatic Agents Phase 3
12 Etoposide phosphate Phase 3
13 Anti-Bacterial Agents Phase 2, Phase 3
14 Antibiotics, Antitubercular Phase 2, Phase 3
15 Alkylating Agents Phase 2, Phase 3
16 Topoisomerase Inhibitors Phase 2, Phase 3
17
Liposomal doxorubicin Phase 2, Phase 3 31703
18
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
19
Parathyroid hormone Approved, Investigational Phase 2 9002-64-6
20
Indinavir Approved Phase 2 150378-17-9 5362440
21
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
22
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
23
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
24
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
25
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
26
leucovorin Approved Phase 2 58-05-9 6006 143
27
Bevacizumab Approved, Investigational Phase 2 216974-75-3
28
Sirolimus Approved, Investigational Phase 2 53123-88-9 5284616 6436030 46835353
29
Everolimus Approved Phase 2 159351-69-6 6442177 70789204
30
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
31
Pembrolizumab Approved Phase 2 1374853-91-4
32
Palbociclib Approved, Investigational Phase 2 571190-30-2 11431660 5005498 5330286
33
Olaparib Approved Phase 2 763113-22-0 23725625
34
Dabrafenib Approved, Investigational Phase 2 1195765-45-7 44462760 44516822
35
afatinib Approved Phase 2 850140-72-6, 439081-18-2 10184653
36
Vemurafenib Approved Phase 2 918504-65-1 23252090 42611257
37
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
38
Trastuzumab Approved, Investigational Phase 2 180288-69-1 9903
39
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
40
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
41
Gemcitabine Approved Phase 2 95058-81-4 60750
42
Tyrosine Approved, Investigational, Nutraceutical Phase 2 60-18-4 6057
43
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
44
Saracatinib Investigational Phase 2 379231-04-6
45 Exatecan Investigational Phase 2 171335-80-1
46
Camptothecin Experimental Phase 2 7689-03-4
47 Soblidotin Investigational Phase 2 149606-27-9
48
protease inhibitors Phase 2
49 HIV Protease Inhibitors Phase 2
50 Cytochrome P-450 CYP3A Inhibitors Phase 2

Interventional clinical trials:

(show top 50) (show all 51)
# Name Status NCT ID Phase Drugs
1 Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcoma (RPS) Unknown status NCT01344018 Phase 3
3 Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
4 MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
5 Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754) Completed NCT02180867 Phase 2, Phase 3 Doxorubicin;Doxorubicin Hydrochloride;Ifosfamide;Pazopanib;Pazopanib Hydrochloride
6 Randomised Trial of Post-Operative Radiotherapy Given to Adult Patients With Extremity Soft Tissue Sarcoma [VORTEX] Completed NCT00423618 Phase 3
7 Randomised Trial Of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide In The First Line Treatment Of Advanced Or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
8 A Phase III Randomized Study of Preoperative Radiation Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcomas (RPS) Completed NCT00091351 Phase 3
9 Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
10 Randomized Study Comparing Neoadjuvant Chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) Combined With Regional Hyperthermia (RHT) Versus Neoadjuvant Chemotherapy Alone in the Treatment of High-Risk Soft Tissue Sarcomas in Adults Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
11 METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP) Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
12 RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
13 TRUSTS: A Phase IIB/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 Phase II Evaluation of Temodal (Temozolomide, Schering) in Previously Treated Advanced Sarcomas Unknown status NCT00003718 Phase 2 temozolomide
15 Randomized Phase II Study of Brostallicin (PNU-166196A) Versus Doxorubicin as First Line Chemotherapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
16 Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
17 A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
18 A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
19 Phase II Trial of Gleevec (Formerly Known as STI571) in Patients With Soft Tissue and Bone Sarcomas: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society Completed NCT00031915 Phase 2 imatinib mesylate
20 A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas Completed NCT00112463 Phase 2 romidepsin
21 Phase II Open-Label Study of Sunitinib Malate (SU011248) in Adult Patients With Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
22 A Phase 2 Study of Intravenous REOLYSIN® (Wild-Type Reovirus) in the Treatment of Patients With Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
23 A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas Completed NCT00245102 Phase 2 sorafenib tosylate
24 A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination With Chemotherapy for Treatment of Osteosarcoma Completed NCT00667342 Phase 2 Cisplatin;Doxorubicin;Methotrexate;Ifosfamide;etoposide
25 A Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
26 Exatecan As Second-Line Treatment In Advanced Adult Soft Tissue Sarcoma: A Phase II - Study Of The EORTC Soft Tissue And Bone Sarcoma Group Completed NCT00041236 Phase 2 exatecan mesylate
27 Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult Completed NCT00003939 Phase 2 trabectedin
28 Phase I/II Trial of Torisel and Liposomal Doxorubicin in Patients With Advanced Soft Tissue and Bone Sarcomas Completed NCT00949325 Phase 1, Phase 2 temsirolimus plus liposomal doxorubicin
29 A Phase II Study of Intravenous TZT-1027, Administered Weekly Times Two, Every Three Weeks, to Patients With Advanced or Metastatic Soft Tissue Sarcomas (STS) With Prior Exposure to Anthracycline-Based Chemotherapy Completed NCT00064220 Phase 2 soblidotin
30 A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
31 Efficacy And Safety Study Of Brostallicin In Patients With Locally Advanced Or Metastatic Soft Tissue Sarcoma Failing One Prior Chemotherapy Treatment Completed NCT00041249 Phase 2 brostallicin
32 Phase II Study of Glivec (Imatinib) in Locally Advanced and/or Metastatic Soft Tissue Sarcomas Expressing the t(17;22)(q22;q13) Translocation Resulting in a COL1A1/PDGF-beta Fusion Protein i.e. DermatoFibroSarcoma Protuberans (DFSP) and Giant Cell Fibroblastoma (GCF) Completed NCT00085475 Phase 2 imatinib mesylate
33 Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma Completed NCT01653028 Phase 2 Alisertib
34 Multicenter Parallel Phase II Trial of BI 2536 Administered as One Hour IV Infusion Every 3 Weeks in Defined Cohorts of Patients With Various Solid Tumors. A New Drug Screening Program of the EORTC Network of Core Institutions (NOCI) Completed NCT00526149 Phase 2 BI 2536
35 Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
36 SU2C-SARC032: A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab With Radiotherapy and Adjuvant Pembrolizumab in Patients With High-Risk, Localized Soft Tissue Sarcoma of the Extremity Recruiting NCT03092323 Phase 2 Pembrolizumab
37 Efficacy and Safety of Targeted Precision Therapy in Refractory Tumor With Druggable Molecular Event Recruiting NCT03239015 Phase 2 Gefitinib;Erlotinib;Afatinib;Trastuzumab;Oxazolidine;Olaparib;Everolimus;Cabozantinib;Vemurafenib;Dabrafenib;Palbociclib
38 A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers Active, not recruiting NCT02392637 Phase 2 Abraxane (Nab-Paclitaxel);Cisplatin;Gemcitabine
39 Phase II Study of Preoperative Intensity-Modulated Radiation Therapy for Soft-Tissue Sarcomas Terminated NCT00740597 Phase 2
40 A Phase I Trial of Postoperative Radiation With Dose-Escalation of A Cox-2 Inhibitor, Celebrex™ (CELECOXIB) in Patients With Soft Tissue Sarcoma of the Extremity Completed NCT00450736 Phase 1 celecoxib
41 Phase I Study To Determine The Safety Of Caelyx (Doxorubin HCI, Pegylated Liposomal) In Combination With Ifosfamide In Previously Untreated Adult Patients With Advanced And/Or Metastatic Soft Tissues Sarcomas Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
42 Phase I Randomized Study of MAGE-12 Peptide Vaccine in Patients With Refractory Metastatic Cancer Expressing MAGE-12 Antigen Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
43 Phase I Study of Doxorubicin HCl Liposome in Pediatric Patients With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
44 VORTEX-BIOBANK: Prospective Sample Collection for the VORTEX Randomised Radiotherapy Trial in Patients With Extremity Soft Tissue Sarcoma [VORTEX BIOBANK] Unknown status NCT00900211
45 Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone Completed NCT00007046
46 A Pilot Study on the Effects of Preoperative Physical Therapy in Adolescents and Young Adults Diagnosed With a Lower Extremity Malignancy Completed NCT01674101
47 Optical Biopsy of Human Skin in Conjunction With Laser Treatment Completed NCT00540566
48 Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas Active, not recruiting NCT03392935
49 An Evaluation of PET/CT Imaging as a Predictor of Disease Free Survival Following Neo-Adjuvant Chemotherapy for Soft Tissue Sarcoma Active, not recruiting NCT00346125 doxorubicin hydrochloride;ifosfamide;pegylated liposomal doxorubicin hydrochloride
50 Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series Not yet recruiting NCT03759327

Search NIH Clinical Center for Fibrous Histiocytoma

Cochrane evidence based reviews: histiocytoma, benign fibrous

Genetic Tests for Fibrous Histiocytoma

Anatomical Context for Fibrous Histiocytoma

MalaCards organs/tissues related to Fibrous Histiocytoma:

40
Bone, Skin, Breast, Lung, Heart, Liver, Kidney

Publications for Fibrous Histiocytoma

Articles related to Fibrous Histiocytoma:

(show top 50) (show all 4553)
# Title Authors PMID Year
1
Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes. 54 61
18300800 2008
2
High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors. 54 61
16740036 2006
3
Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa. 54 61
16640542 2006
4
Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. 54 61
15884099 2005
5
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. 54 61
12915480 2003
6
S100A6 expression in fibrohistiocytic lesions. 54 61
11401666 2001
7
Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11. 54 61
11063792 2000
8
Fibrous histiocytoma and fibrous tissue tumors of the orbit. 54 61
10026737 1999
9
Verocay body--prominent cutaneous schwannoma. 54 61
9185909 1997
10
Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. 54 61
7681857 1993
11
Oral submucosal dendrocytes: factor XIIIa+ and CD34+ dendritic cell populations in normal tissue and fibrovascular lesions. 54 61
1282135 1992
12
Fibrous histiocytoma of the tongue base. 54 61
2163249 1990
13
The first total vertebral involvement of benign fibrous histiocytoma: A case report and literature review. 61
31908914 2020
14
Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. 61
32016322 2020
15
Cutaneous Syncytial Myoepithelioma: A Nondescript Skin Tumor With Serious Diagnostic Pitfalls. 61
31587595 2020
16
Aneurysmal benign fibrous histiocytoma of the anal canal: a rare differential diagnosis. 61
31845025 2020
17
Cutaneous soft tissue tumors: how do we make sense of fibrous and "fibrohistiocytic" tumors with confusing names and similar appearances? 61
31653978 2020
18
[Clinicopathologic and molecular characteristics of myxoid angiomatoid fibrous histiocytoma]. 61
32023767 2020
19
Malignant fibrous neoplasms of long bones: analysis of the surveillance, epidemiology, and end results database from 1973 to 2015. 61
31969161 2020
20
Retroperitoneal sarcomas: from diagnosis to treatment. Case series and review of the literature. 61
32038009 2020
21
Primary undifferentiated pleomorphic sarcoma (Malignant fibrous histiocytoma) of the lung: A case report. 61
31998481 2020
22
Pedunculated aneurysmal fibrous histiocytoma with increased 18 F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography. 61
31953877 2020
23
Uterine pleomorphic leiomyosarcoma with osteoclastic giant cells: Case report with peritoneal washing cytology and cell block study. 61
31932012 2020
24
The Management of Head and Neck Sarcoma. 61
31934973 2020
25
Cutaneous "fibroma-like" perivascular epithelioid cell tumor: A case report and review of literature. 61
31943330 2020
26
Pleomorphic malignant fibrous histiocytoma in bladder diverticulum. 61
31788429 2020
27
Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion. 61
31305268 2019
28
A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases. 61
31520939 2019
29
Epithelioid Fibrous Histiocytoma: A Concise Review. 61
30289773 2019
30
A rare case of benign fibrous histiocytoma of the cornea. 61
31755460 2019
31
Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4. 61
31696221 2019
32
Malignant fibrous histiocytoma arising from the renal capsule and gene mutation screening: A case report. 61
31641593 2019
33
Posterior retroperitoneoscopic adrenalectomy for pediatric adrenal tumors. 61
30878147 2019
34
MUC4 Expression in Angiomatoid Fibrous Histiocytoma. 61
31652145 2019
35
Primary Adrenal Angiomatoid Fibrous Histiocytoma With Novel EWSR1-ATF1 Gene Fusion Exon-Exon Breakpoint. 61
30823861 2019
36
Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register. 61
31287163 2019
37
Effects of MFHAS1 on cognitive impairment and dendritic pathology in the hippocampus of septic rats. 61
31476310 2019
38
Surgical Treatment of Oral Cavity Nodular Fasciitis. 61
31609954 2019
39
Differing characteristics of cartilaginous lesions of the larynx. 61
31338576 2019
40
Small soft tissue masses indeterminate at imaging: histological diagnoses at a tertiary orthopedic oncology clinic. 61
30903259 2019
41
Spontaneous pancreatic undifferentiated pleomorphic sarcoma in a laboratory rat: A case report. 61
31773099 2019
42
Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases. 61
31364245 2019
43
SOX9 Immunohistochemistry in the Distinction of Angiomatoid Fibrous Histiocytoma From Histologic Mimics: Diagnostic Utility and Pitfalls. 61
31567275 2019
44
Angiomatoid Fibrous Histiocytoma Mimicking Eosinophilic Granuloma in a Pediatric Patient. 61
31233924 2019
45
A case of childhood intracerebral angiomatoid fibrous histiocytoma radiologically mimicking infection and with unusual immunopositivity for placental alkaline phosphatase. 61
30990406 2019
46
[Atypical fibroxanthoma and pleomorphic dermal sarcoma]. 61
31468069 2019
47
Treatment of spinal malignant fibrous histiocytoma, a case report and literature review. 61
30527900 2019
48
Management of giant benign fibrous histiocytoma in the spinal region with pleural involvement: A case report. 61
31574815 2019
49
Small Benign Storiform Fibrous Tumor (Fibrous Histiocytoma) of the Conjunctival Substantia Propria in a Child: Review and Clarification of Biologic Behavior. 61
30893190 2019
50
Hypertensive Crisis during Microwave Ablation of Adrenal Neoplasms: A Retrospective Analysis of Predictive Factors. 61
31155498 2019

Variations for Fibrous Histiocytoma

Expression for Fibrous Histiocytoma

Search GEO for disease gene expression data for Fibrous Histiocytoma.

Pathways for Fibrous Histiocytoma

Pathways related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.53 MITF FUS EWSR1 ATF1
2 11.19 VIM DES ACTC1
3 10.34 MITF CREB1 ATF1

GO Terms for Fibrous Histiocytoma

Biological processes related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 muscle filament sliding GO:0030049 9.13 VIM DES ACTC1
2 glomerular endothelium development GO:0072011 8.62 PECAM1 CD34

Molecular functions related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.23 VIM S100B FUS EWSR1 DES CREB1

Sources for Fibrous Histiocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....